Home - Clinical Trials Arena
网页Clinical Trials Arena is a website that covers the latest news, analysis and data insights on clinical trials and drug development. Find out about the latest trends, innovations and challenges in the industry, and access reports, buyer's guides and digital magazines.
Most significant clinical trials of 2023
网页2023年12月27日 · Learn about the innovative drugs and gene therapies that made it to market in 2023, such as Lilly's donanemab for Alzheimer's and Vertex's exa-cel for sickle cell disease. Also, see the challenges and trends in clinical trial initiation and termination.
DermaSensor’s skin cancer detection device helps clinicians in ...
网页2 天之前 · DermaSensor’s device is a spectroscopy-based objective tool to help clinicians evaluate suspected lesions for some of the most common forms of skin cancer, including basal cell carcinoma, squamous cell carcinoma and melanoma.. The device secured US Food and Drug Administration (FDA) clearance in January 2024, supported by data from a pivotal study that enrolled more than 1,000 patients and ...
Clinical Trials Arena Review 2023 - Clinical Trials Arena
网页2023年12月4日 · As the year comes to a close the Clinical Trials Arena team look back at the stand-out trials of 2023. Kiays Khalil December 4, 2023. The year 2023 has seen the first CRISPR therapy indicate it could be a one-time success for patients with sickle cell disease as well as more movement in the field of Alzheimer’s disease.
Features - Clinical Trials Arena
网页Pipeline Moves: Phase III completion for Corcept’s relacorilant. Clinical Trials Arena Team. Features.
Reports - Clinical Trials Arena
网页Clinical Trials Arena Reports. GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the pharmaceuticals and healthcare market. Reports cover market growth forecasts, trends and research ...
Insights - Clinical Trials Arena
网页Q2 2024 update: social responsibility related hiring actvity in the pharma industry. The global pharmaceutical industry experienced a 22% rise in new job postings related to social responsibility in Q2 2024 compared…. Jobs.
Clinical trials in China - is it worth climbing the great wall?
网页2022年5月13日 · The great wall: why overseas sponsors are yet to fully tap into China’s clinical trial resources. China is an attractive study destination, yet our data-driven analysis shows the country’s clinical trial industry is still insular. Clinical Trials Arena maps the barricades. Reynald Castañeda and Andrew Hillman May 13, 2022. Need to know ...
Aclaris doses first subject in Phase IIa atopic dermatitis trial
网页4 天之前 · Aclaris Therapeutics has dosed the first subject in the Phase IIa clinical trial of ATI-2138 to treat moderate to severe atopic dermatitis (AD). The open-label trial aims to assess the safety, tolerability, pharmacokinetics, and efficacy of ATI-2138 in AD patients over 12 weeks. Being conducted in the US, the trial plans to enrol approximately ...
Gilead’s lenacapavir: HIV prospects strongest in long-acting …
网页2021年8月25日 · Gilead’s lenacapavir will find its strongest niche as a long-acting HIV combination treatment, experts said. Manasi Vaidya August 25, 2021. Gilead announced a collaboration with Merck in March to study lenacapavir with islatravir, a nucleoside reverse transcriptase translocation inhibitor (NRTTI), which is also a new drug class in HIV.
跳至内容